Rusan Pharma launches R&D centre at Kandla SEZ

Rusan Pharma signs $20 million per annum deal with Brazil Health Ministry for smoking cessation programme

Rusan Pharma has launched Rs 100-crore state-of-the-art R&D centre, Navin Saxena Research & Technology (NSRT), Quest Care, a custom-built clinical research organisation (CRO) and a specialised manufacturing unit for transdermal patches at the Kandla Special Economic Zone (SEZ), Gujarat. Rusan Pharma will manufacture nicotine transdermal patches in India.

The three units will handle the myriad aspects of addiction and pain management drug manufacture and export as a part of their portfolio, including research and innovation, licensing, IPR, patenting, quality assurance. The units will offer employment opportunities not only to the local population but also to the scientists from across India and abroad.

NSRT is a dedicated R&D facility with state-of-the-art technology and equipment. Research at NSRT will focus on pain, addiction, CNS and orphan diseases, drug delivery and platform technologies. It has been set up with a vision to develop, register and license its new products to third parties and aims to undertake contract research and joint development projects.

Quest Care is a modern, well-designed, custom-built CRO with five independent clinics having a total of 104 beds. It will offer services such as medical writing as per ICH guidelines, bioavailability/ bioequivalence and end point studies, and bio-analysis. It is compliant with all regulatory requirements for clinical research. Spread over about 70,000 square feet of area, the CRO incorporates various labs, speciality units and a library of archives.

Dr Navin Saxena, Chairman & Founder, Rusan Pharma also announced a deal between Brazil Health Ministry and Rusan Pharma for $20million per annum for their programme for smoking cessation.

The pre-inaugural event saw the signing of a memorandum of understanding between NSRT, Moscow State University (Russia), Symbiosis College Pune, The Maharaja Sayajirao University of Baroda and IIT Kanpur. The MoU highlighted NSRT’s commitment to collaborative research.

EP News BureauMumbai

Quest CareRusan Pharma